78.99
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $78.99, with a volume of 4.18M.
It is up +0.42% in the last 24 hours and up +2.42% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$78.66
Open:
$79.05
24h Volume:
4.18M
Relative Volume:
0.60
Market Cap:
$100.19B
Revenue:
$393.94B
Net Income/Loss:
$428.00M
P/E Ratio:
206.46
EPS:
0.3826
Net Cash Flow:
$6.29B
1W Performance:
+1.07%
1M Performance:
+2.42%
6M Performance:
+18.28%
1Y Performance:
+38.41%
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
78.99 | 99.85B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
324.21 | 291.28B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
317.78 | 69.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
264.58 | 68.49B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
252.04 | 30.20B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Jim Cramer on CVS CEO: “I Really Like What David Joyner’s Doing With the Turnaround” - Insider Monkey
CVS Health: Can Its New PBM Strategy Finally Cut America’s Drug Costs? - Smartkarma
E-Pharmacy Market Set to Quadruple, Reaching USD 435.82 Billion by 2034, Reports Towards Healthcare - GlobeNewswire Inc.
What the charts say about CVS Health Corporation todayWall Street Watch & Low Drawdown Trading Strategies - newser.com
Will CVS Health Corporation bounce back from current supportCPI Data & Fast Gaining Stock Strategy Reports - newser.com
CVS Health Corporation $CVS Shares Purchased by Achmea Investment Management B.V. - MarketBeat
Will CVS Health Corporation (CVS) stock beat revenue estimates2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
Patients win when healthcare providers and insurers come together | Column - Tampa Bay Times
Can CVS Health Corporation (Common Stock) (CVS0) stock reach $200 price targetProduct Launch & AI Powered Market Entry Ideas - newser.com
Should you wait for a breakout in CVS Health CorporationInsider Selling & AI Enhanced Trading Alerts - newser.com
Short interest data insights for CVS Health CorporationTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Will CVS Health Corporation stock benefit from automation2025 Volume Leaders & Safe Entry Zone Tips - fcp.pa.gov.br
Is CVS Health Corporation stock positioned for secular growth2025 Price Targets & Community Consensus Trade Signals - fcp.pa.gov.br
Cushman & Wakefield Brokers $57M Sale of Distribution Center in Orlando - REBusinessOnline
CVS class action alleges company charged illegal tobacco surcharge - Class Action Lawsuits
NewSquare Capital LLC Purchases 4,854 Shares of CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earningsQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
NJ State Employees Deferred Compensation Plan Decreases Holdings in CVS Health Corporation $CVS - MarketBeat
Will CVS Health Corporation (CVS) stock maintain strong growthMarket Activity Report & Safe Capital Allocation Plans - newser.com
Is CVS Health Corporation stock positioned for digital transformationQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
CVS Unit Omnicare Taps Alvarez & Marsal for Operational Help - MSN
TD Cowen Increases CVS Health (NYSE:CVS) Price Target to $100.00 - MarketBeat
Florida firm buys massive CVS-leased distribution facility for $57M, signaling shift in investment strategy - The Business Journals
Bank of New York Mellon Corp Sells 325,652 Shares of CVS Health Corporation $CVS - MarketBeat
Hussman Strategic Advisors Inc. Takes $2.17 Million Position in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock supported by strong fundamentalsEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Y Intercept Hong Kong Ltd Acquires New Position in CVS Health Corporation $CVS - MarketBeat
Why global investors buy CVS Health Corporation stockJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com
CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continua - GuruFocus
CVS Health price target raised to $100 from $99 at TD Cowen - TipRanks
CVS Health (NYSE:CVS) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
CVS Health: Undervalued And Ripe For Growth (NYSE:CVS) - Seeking Alpha
CVS Health Corporation $CVS Stake Lowered by Triglav Investments D.O.O. - MarketBeat
Versor Investments LP Increases Stake in CVS Health Corporation $CVS - MarketBeat
Burney Co. Decreases Position in CVS Health Corporation $CVS - MarketBeat
4,657 Shares in CVS Health Corporation $CVS Bought by Sebold Capital Management Inc. - MarketBeat
AlphaStar Capital Management LLC Makes New $385,000 Investment in CVS Health Corporation $CVS - MarketBeat
State of Michigan Retirement System Has $27.12 Million Position in CVS Health Corporation $CVS - MarketBeat
Welch & Forbes LLC Trims Stake in CVS Health Corporation $CVS - MarketBeat
GHP Investment Advisors Inc. Buys 6,476 Shares of CVS Health Corporation $CVS - MarketBeat
IFG Advisory LLC Sells 4,071 Shares of CVS Health Corporation $CVS - MarketBeat
Spire Wealth Management Sells 64,594 Shares of CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock affected by interest rate hikesMarket Performance Report & Growth Focused Investment Plans - newser.com
Is now a turning point for CVS Health Corporation2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
How CVS Health Corporation (CVS) stock performs in easing cyclesProduct Launch & Safe Swing Trade Setup Alerts - newser.com
Is CVS Health Corporation stock a buy for dividend growth2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
CVS Health (NYSE:CVS) Price Target Raised to $90.00 - MarketBeat
CVS Health (NYSE:CVS) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Is Wall Street Bullish or Bearish on CVS Health Stock? - MSN
6,521 Shares in CVS Health Corporation $CVS Acquired by Syverson Strege & Co - MarketBeat
Mesirow Financial Investment Management Inc. Decreases Position in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):